Cardiovascular-Related Mortality Risk in Primary Myelofibrosis in Pre-Ruxolitinib and Ruxolitinib Eras

被引：0
|
作者：
Ilerhunmwuwa, Nosakhare Paul [1 ]
Rayapureddy, Aditya Keerthi [2 ]
Uche, Ifeanyi Nnamdi [1 ]
Wasifuddin, Mustafa [3 ]
Wang, Jen-Chin [4 ]
机构：
[1] Brookdale Univ Hosp & Med Ctr, Dept Med, Brooklyn, NY USA
[2] Interfaith Med Ctr, Dept Med, Brooklyn, NY USA
[3] Brookdale Univ Hosp & Med Ctr, Brooklyn, NY USA
[4] Brookdale Univ Hosp & Med Ctr, Div Hematol Oncol, Brooklyn, NY USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-174418
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Second primary malignancies in patients receiving treatment with ruxolitinib for myelofibrosis - a regional experience
    Schofield, J.
    Wells, R.
    Nicholson, T.
    Butt, N. M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 77 - 77
  • [42] The impact of ruxolitinib treatment on inflammation-mediated comorbidities in myelofibrosis and related neoplasms
    Bjorn, Mads Emil
    Hasselbalch, Hans Carl
    CLINICAL CASE REPORTS, 2015, 3 (06): : 499 - 503
  • [43] SAFETY AND EFFICACY OF RUXOLITINIB IN AN ELDERLY PATIENT WITH PRIMARY MYELOFIBROSIS AND ACTIVE HCV AND HBV RELATED-LIVER DISEASE
    De Lorenzo, S.
    Barone, M.
    Rivellini, F.
    Petrizzi, V. Belsito
    Califano, C.
    Langella, M.
    Iovino, V.
    Campana, A.
    De Prisco, P.
    Ingenito, C.
    D'Arco, A. M.
    HAEMATOLOGICA, 2015, 100 : 111 - 111
  • [44] Ruxolitinib discontinuation syndrome: incidence, risk factors, and management in 251 patients with myelofibrosis
    Francesca Palandri
    Giuseppe Alberto Palumbo
    Elena Maria Elli
    Nicola Polverelli
    Giulia Benevolo
    Bruno Martino
    Elisabetta Abruzzese
    Mario Tiribelli
    Alessia Tieghi
    Roberto Latagliata
    Francesco Cavazzini
    Micaela Bergamaschi
    Gianni Binotto
    Monica Crugnola
    Alessandro Isidori
    Giovanni Caocci
    Florian Heidel
    Novella Pugliese
    Costanza Bosi
    Daniela Bartoletti
    Giuseppe Auteri
    Daniele Cattaneo
    Luigi Scaffidi
    Malgorzata Monica Trawinska
    Rossella Stella
    Fiorella Ciantia
    Fabrizio Pane
    Antonio Cuneo
    Mauro Krampera
    Gianpietro Semenzato
    Roberto Massimo Lemoli
    Alessandra Iurlo
    Nicola Vianelli
    Michele Cavo
    Massimo Breccia
    Massimiliano Bonifacio
    Blood Cancer Journal, 11
  • [45] Ruxolitinib discontinuation syndrome: incidence, risk factors, and management in 251 patients with myelofibrosis
    Palandri, Francesca
    Palumbo, Giuseppe Alberto
    Elli, Elena Maria
    Polverelli, Nicola
    Benevolo, Giulia
    Martino, Bruno
    Abruzzese, Elisabetta
    Tiribelli, Mario
    Tieghi, Alessia
    Latagliata, Roberto
    Cavazzini, Francesco
    Bergamaschi, Micaela
    Binotto, Gianni
    Crugnola, Monica
    Isidori, Alessandro
    Caocci, Giovanni
    Heidel, Florian
    Pugliese, Novella
    Bosi, Costanza
    Bartoletti, Daniela
    Auteri, Giuseppe
    Cattaneo, Daniele
    Scaffidi, Luigi
    Trawinska, Malgorzata Monica
    Stella, Rossella
    Ciantia, Fiorella
    Pane, Fabrizio
    Cuneo, Antonio
    Krampera, Mauro
    Semenzato, Gianpietro
    Lemoli, Roberto Massimo
    Iurlo, Alessandra
    Vianelli, Nicola
    Cavo, Michele
    Breccia, Massimo
    Bonifacio, Massimiliano
    BLOOD CANCER JOURNAL, 2021, 11 (01)
  • [46] Impact of Pre-Graft Ruxolitinib on Post-Transplantation Outcome in Myelofibrosis Patients
    Villar, Sara
    Chevret, Sylvie
    Poire, Xavier
    Charbonnier, Amandine
    Chevallier, Patrice
    Bourhis, Jean-Henri
    Forcade, Edouard
    Chantepie, Sylvain
    Beauvais, David
    Raus, Nicole
    Bay, Jacques-Olivier
    Loschi, Michael
    Devillier, Raynier
    Duléry, Remy
    Ceballos, Patrice
    Rubio, Marie Thérèse
    Beguin, Yves
    Nguyen, Stephanie
    Robin, Marie
    BLOOD, 2021, 138 : 1844 - +
  • [47] Ruxolitinib Treatment in a Patient with Primary Myelofibrosis Resistant to Conventional Therapies and Splenectomy: A Case Report
    Ayh, Meltem
    Ozcan, Muhit
    Seval, Guldane Cengiz
    TURKISH JOURNAL OF HEMATOLOGY, 2015, 32 (02) : 180 - 183
  • [48] Acute respiratory distress syndrome in a patient with primary myelofibrosis after ruxolitinib treatment discontinuation
    Yan Beauverd
    Kaveh Samii
    International Journal of Hematology, 2014, 100 : 498 - 501
  • [49] Osteolytic Lesions in Primary Myelofibrosis and Effect of Ruxolitinib Therapy: Report of a Case and Literature Review
    Bucelli, Cristina
    Cattaneo, Daniele
    Valli, Viviana Beatrice
    Levati, Giorgia Virginia
    Lonati, Silvia
    Gianelli, Umberto
    Iurlo, Alessandra
    CHEMOTHERAPY, 2018, 63 (06) : 340 - 344
  • [50] Acute respiratory distress syndrome in a patient with primary myelofibrosis after ruxolitinib treatment discontinuation
    Beauverd, Yan
    Samii, Kaveh
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2014, 100 (05) : 498 - 501
12345